StonvexLoading…
StonvexStonvexStonvexCore line items from ADMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $145.38M | $114.49M | $510.17M | $371.01M | $236.79M |
Operating Income | Not available | $58.27M | $191.44M | $128.69M | $77.68M |
Net Income | Not available | $45.33M | $146.93M | $97.55M | $34.22M |
EPS (Diluted) | $0.23 | $0.19 | $0.60 | $0.40 | $0.25 |
Total Assets | Not available | $665.18M | $624.24M | $568.69M | $558.38M |
Total Liabilities | Not available | $274.86M | $146.92M | $137.50M | $160.06M |
Cash & Equivalents | Not available | $138.15M | $87.63M | $61.38M | $90.28M |
Free Cash Flow OCF − CapEx | Not available | $55.71M | $27.82M | $-6.73M | $-5.66M |
Shares Outstanding | Not available | 232.29M | 237.87M | 238.33M | 238.57M |